Oligonucleotides for modulating target RNA activity

Details for Australian Patent Application No. 2007323469 (hide)

Owner Querdenker ApS

Inventors Moller, Thorleif

Agent FB Rice

Pub. Number AU-A-2007323469

PCT Pub. Number WO2008/061537

Priority 60/888,094 04.02.07 US; 60/888,095 04.02.07 US; PA 2006 01543 23.11.06 DK; PA 2007 01081 24.07.07 DK; PA 2006 01544 23.11.06 DK

Filing date 23 November 2007

Wipo publication date 29 May 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/061537 Priority application(s): WO2008/061537

10 September 2009 Assignment before Grant

  Querdenker ApS The application has been assigned to Mirx Therapeutics ApS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323516-Supported changeable frame for soil working implements

2007323468-Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye